查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1677163

按类型、行业应用和最终用户分類的数位诊断市场 - 2025 年至 2030 年的全球预测

Digital Diagnostics Market by Type, Industry Applications, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计数位诊断市场规模在 2024 年将达到 15.4 亿美元，在 2025 年将达到 16.3 亿美元，复合年增长率为 6.17%，到 2030 年将达到 22.1 亿美元。

主要市场统计数据
基准年 2024 年 15.4亿美元
预计 2025 年 16.3亿美元
预测年份 2030 22.1亿美元
复合年增长率（%） 6.17％

在快速发展的医疗保健领域，数位诊断正在重新定义疾病的检测和管理方式。人工智慧、影像技术和分子遗传学的最新进展预示着一个变革时代的到来，诊断方法将变得越来越有效和精确。推动这项变革的是跨学科研究和技术突破的融合，将数位化功能与传统诊断程序结合。技术开发人员和临床医生之间的策略互动正在催化创新，不仅可以优化诊断准确性，而且可以改善多种临床条件下的患者治疗结果。

在此背景下，从行业专家到医疗保健决策者的相关人员都在关注数位诊断在重塑患者护理途径中发挥的关键作用。就像一场精心编配的交响乐，新的数位工具和传统调查方法的融合正在创造一个未来，在那里早期发现、个人化治疗和改善疾病管理都是可以实现的目标。这些变化在快速诊断至关重要的环境中尤其重要，并为全球向资料主导的医疗决策奠定了基础。

这项全面概述涵盖了数位诊断市场的方面，并提供了有关市场趋势、转型转变、細項分析、区域差异等方面的相关见解。接下来的章节将深入探讨推动市场发展的市场催化剂，并深入说明这一重要领域所面临的机会和挑战。

重新定义数位诊断格局的转型

过去几年，数位诊断领域发生了前所未有的变化。新兴技术正在弥合诊断成像、即时病患监测和精确分子分析之间的差距。最显着的变化之一是高阶分析技术越来越多地融入诊断业务。增强的成像技术和机器学习演算法现在是关键驱动因素，可以实现更准确、更快的疾病识别。资料处理和云端连接方面的创新也为不同地区和研究机构之间的更大合作铺平了道路。

此外，行动医疗应用程式和先进诊断设备的整合正在促进向偏远和服务不足的地区提供医疗服务。这项进步不仅使人们能够更自由地使用尖端诊断工具，而且还缩短了从初次咨询到明确诊断的时间。数位病理学、放射学和穿戴式健康监测系统现已成为旨在彻底改变传统护理模式的生态系统的核心。随着对研究的持续投入和强有力的监管重点，市场正在见证向早期疾病检测和个人化治疗策略的稳步转变。

随着医疗保健产业从被动护理转向主动护理，这些趋势强调了拥抱数位转型的重要性。资料科学与传统诊断之间的协同效应正在创建一个可以适应新的健康威胁和不断变化的患者需求的弹性框架，确保医疗保健服务的强劲和可扩展的未来。

揭示市场细微差别的关键细分洞察

详细的細項分析为数位诊断市场的基本动态提供了细緻的观点。按类型评估市场，广泛的研究表明，它可以细分为数位皮肤病学、数位病理学、数位放射线、行动健康诊断、分子和基因诊断以及可穿戴和远端监控。此分类强调了技术进步和数位方法日益融入诊断过程的各个方面。

此外，当我们研究行业应用时，我们发现数位诊断越来越多地影响心臟病学、感染疾病、神经病学和肿瘤学等领域的治疗方式。这些领域不仅代表了广泛的医疗保健挑战，而且代表了透过提高诊断准确性和早期疗育实现成长机会的重要领域。作为这些见解的补充，基于最终用户属性的细分确定了研究机构、诊断实验室和影像中心、医院和诊所以及学术医疗中心所发挥的关键作用。每个细分市场都利用专门的数位工具来满足特定的医疗保健需求，为整个市场做出了独特的贡献。

对细分市场的彻底分析将有助于更清楚地了解不断变化的需求，并推动创新以解决需求驱动的诊断问题。因此，透过整合来自各个细分观点的见解，相关人员可以更好地制定产品开发、市场进入策略和资源分配策略，以有效地将技术进步与临床优先事项和患者护理标准结合起来。

目录

第 1 章 简介

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 有利的政府政策和监管支持为数位诊断提供了重大推动力
      • 远端医疗和远端监控解决方案的广泛采用将推动数位诊断的整合
      • 慢性病增多，需要早期发现和准确的诊断解决方案
    • 限制因素
      • 引进先进技术及训练专业人员高成本
    • 机会
      • 透过数位诊断结合穿戴式科技开发个人化医疗
      • 建立策略伙伴关係和合作关係，利用先进的资料分析简化数位诊断工作流程
    • 任务
      • 资料隐私问题与网路安全风险削弱消费者信任
  • 市场区隔分析
    • 类型：利用智慧型手机连接和行动装置的行动医疗（行动医疗）诊断需求不断增长
    • 最终用户：数位诊断越来越多地应用于诊断实验室和成像中心，以实现满足这些严格要求的智慧主导分析。
  • 波特五力分析
  • PESTEL 分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章 数位诊断市场按类型

  • 数位皮肤病学
  • 数位病理学
  • 数位放射线
  • 行动医疗（行动医疗）诊断
  • 分子和遗传诊断
  • 穿戴式装置和远端监控

第七章 数位诊断市场按行业应用

  • 心臟病学
  • 感染疾病
  • 神经病学
  • 肿瘤学

第 8 章 数位诊断市场（按最终用户）

  • 诊断实验室和影像中心
  • 医院和诊所
  • 研究所和学术医疗中心

9. 美洲数位诊断市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第 10 章：亚太地区数位诊断市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第 11 章欧洲、中东和非洲数位诊断市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章 竞争格局

  • 2024 年市场占有率分析
  • FPNV 定位矩阵，2024 年
  • 竞争情境分析
  • 战略分析与建议

公司列表

  • Abbott Laboratories
  • Agilent Technologies
  • Aidoc
  • Becton, Dickinson, and Company
  • Bio-Rad Laboratories
  • Butterfly Network, inc
  • CANON MEDICAL SYSTEMS CORPORATION
  • Carestream Health, Inc.
  • Danaher Corporation
  • FUJIFILM Holdings America Corporation
  • GE Healthcare Technologies, Inc.
  • Google LLC
  • Guardant Health, Inc.
  • Hologic, Inc.
  • International Business Machines Corp.
  • Invitae Corporation
  • Koninklijke Philips NV
  • Microsoft Corporation
  • NVIDIA Corporation
  • PathAI, Inc.
  • Qiagen NV
  • Roche Diagnostics Corporation
  • Siemens Healthineers
  • Tempus AI, Inc.
  • Thermo Fisher Scientific
Product Code: MRR-A40F58415944

The Digital Diagnostics Market was valued at USD 1.54 billion in 2024 and is projected to grow to USD 1.63 billion in 2025, with a CAGR of 6.17%, reaching USD 2.21 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 1.54 billion
Estimated Year [2025] USD 1.63 billion
Forecast Year [2030] USD 2.21 billion
CAGR (%) 6.17%

In the rapidly evolving realm of healthcare, digital diagnostics are redefining the way diseases are detected and managed. Recent advances in artificial intelligence, imaging technology, and molecular genetics underline a transformative era where diagnostic methodologies are becoming increasingly effective and precise. This evolution is spurred by an amalgamation of cross-disciplinary research and technological breakthroughs that integrate digital capabilities into conventional diagnostic procedures. The strategic interplay between technology developers and clinical practitioners is catalyzing innovations that not only optimize diagnostic accuracy but also enhance patient outcomes across multiple clinical conditions.

In this context, stakeholders ranging from industry experts to healthcare decision-makers have turned their attention to the critical role played by digital diagnostics in reshaping patient care pathways. Much like a carefully orchestrated symphony, the integration of emerging digital tools with traditional methodologies is crafting a future where early detection, personalized treatment, and improved disease management stand as achievable goals. These changes are particularly significant in settings where rapid diagnosis is paramount, thereby laying the foundation for a global shift towards data-driven medical decision-making.

This comprehensive overview captures the multifaceted dimensions of the digital diagnostics market, providing pertinent insights into market trends, transformative shifts, segmentation analyses, and regional variations. The following sections delve deeper into the catalysts driving market evolution and present a detailed narrative on both the opportunities and challenges that define this vital sector.

Transformative Shifts Redefining the Digital Diagnostics Landscape

The landscape of digital diagnostics has experienced unprecedented transformation over the past few years. Emerging technologies are bridging the gap between diagnostic imaging, real-time patient monitoring, and precise molecular analysis. One of the most notable shifts is the increasing integration of advanced analytics into diagnostic practices. Enhanced imaging technologies and machine learning algorithms are now key drivers, enabling more accurate and faster disease identification. Innovations in data processing and cloud connectivity have also paved the way for increased collaboration across different geographic regions and research institutions.

Additionally, the convergence of mobile health applications with sophisticated diagnostic equipment is making it easier to deliver healthcare services to remote and underserved areas. This evolution not only democratizes access to state-of-the-art diagnostic tools but also reduces the time elapsed between initial consultation and confirmatory diagnosis. Digital pathology, radiology, and wearable health monitoring systems are now central to an ecosystem designed to revolutionize traditional care models. With ongoing investments in research and a strong regulatory focus, the market is witnessing a steady transition toward early disease detection and personalized treatment strategies.

As the healthcare industry moves from reactive to proactive care, such trends underscore the importance of embracing digital transformation. The synergy between data science and traditional diagnostics is creating a resilient framework that can adapt to emerging health threats and shifting patient needs, ensuring a robust and scalable future for healthcare delivery.

Key Segmentation Insights Revealing Market Nuances

Detailed segmentation analysis offers a nuanced perspective into the underlying dynamics of the digital diagnostics market. When evaluating the market based on type, extensive studies reveal a division into digital dermatology, digital pathology, digital radiology, mobile health diagnostics, molecular and genetic diagnostics, and wearable and remote monitoring. This categorization highlights both the technical advancements and the growing integration of digital methodologies into every facet of diagnostic processes.

Further, a look into industry applications reveals that digital diagnostics are increasingly influencing the way we approach treatment in areas such as cardiology, infectious diseases, neurology, and oncology. These areas represent not only a broad spectrum of medical challenges but also capture the key opportunities for growth through enhanced diagnostic precision and early intervention. Complementing these insights, the segmentation based on end-user demographics pinpoints the critical roles played by diagnostic laboratories and imaging centers, hospitals and clinics, and research institutes alongside academic medical centers. Each of these segments contributes uniquely to the overall market landscape by leveraging specialized digital tools to address specific medical requirements.

The deliberate dissection of market segments facilitates a clearer understanding of the evolving demand, driving innovations that cater to tailored diagnostic needs. Hence, by interweaving insights from various segmentation perspectives, stakeholders can better strategize product development, market entry tactics, and resource allocations, thereby ensuring that technological advancements are effectively aligned with clinical priorities and patient care standards.

Based on Type, market is studied across Digital Dermatology, Digital Pathology, Digital Radiology, Mobile Health (mHealth) Diagnostics, Molecular & Genetic Diagnostics, and Wearable & Remote Monitoring.

Based on Industry Applications, market is studied across Cardiology, Infectious Diseases, Neurology, and Oncology.

Based on End-User, market is studied across Diagnostic Laboratories & Imaging Centers, Hospitals & Clinics, and Research Institutes & Academic Medical Centers.

Key Regional Insights Shaping Global Market Trends

Regional dynamics play a pivotal role in dictating the pace and direction of the digital diagnostics market. In the Americas, technological advancements and a strong focus on healthcare innovation create a fertile environment for the adoption of digital solutions. This region benefits from extensive research and high capital investments, leading to rapid market penetration and significant improvements in public health outcomes.

Europe, Middle East & Africa exhibit unique patterns driven by diverse regulatory landscapes, varying levels of technological adoption, and distinct demographic challenges. Regulatory frameworks here are increasingly adapting to integrate digital health trends into clinical practice, providing new avenues for market expansion and horizontal growth in services.

Meanwhile, Asia-Pacific stands out as a region with immense growth potential. The confluence of a large population base, increasing healthcare expenditures, and government initiatives targeted at digital transformation accelerates the demand for innovative diagnostics. These regional insights collectively underscore the importance of tailoring digital diagnostic strategies to local market conditions, ensuring that technological leaps in one part of the world can serve as blueprints for innovations elsewhere.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Shaping the Digital Diagnostics Frontier

Market leadership in digital diagnostics is strongly influenced by several high-impact companies. Giants like Abbott Laboratories and Agilent Technologies are pioneering the integration of robust hardware with sophisticated digital solutions. Companies such as Aidoc and Becton, Dickinson, and Company have demonstrated the power of artificial intelligence to transform diagnostic imaging and workflow efficiencies in clinical settings. Bio-Rad Laboratories, along with Butterfly Network, inc, are advancing how diagnostics are conducted by incorporating genomic insights with digital platforms.

Established names like CANON MEDICAL SYSTEMS CORPORATION and Carestream Health, Inc. continue to contribute significantly by refining imaging technology and diagnostic software. Firms such as Danaher Corporation and FUJIFILM Holdings America Corporation have accelerated the adoption of digital pathology and radiology systems; while GE Healthcare Technologies, Inc. and Google LLC are setting benchmarks for innovative integration of digital ecosystems in healthcare.

Additionally, Guardant Health, Inc., Hologic, Inc., and International Business Machines Corp. are noteworthy for harnessing data analytics to improve diagnostic precision. Invitae Corporation, Koninklijke Philips N.V., and Microsoft Corporation have also been central to pushing the boundaries in areas such as molecular diagnostics and remote health monitoring. In recent years, companies like NVIDIA Corporation, PathAI, Inc., Qiagen N.V., and Roche Diagnostics Corporation have emerged as frontrunners by merging computational advancements with traditional diagnostics. This trend is further bolstered by Siemens Healthineers, Tempus AI, Inc., and Thermo Fisher Scientific, whose commitment to continuous innovation enables the market to progress toward more personalized, accurate, and efficient diagnostic solutions.

The report delves into recent significant developments in the Digital Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Aidoc, Becton, Dickinson, and Company, Bio-Rad Laboratories, Butterfly Network, inc, CANON MEDICAL SYSTEMS CORPORATION, Carestream Health, Inc., Danaher Corporation, FUJIFILM Holdings America Corporation, GE Healthcare Technologies, Inc., Google LLC, Guardant Health, Inc., Hologic, Inc., International Business Machines Corp., Invitae Corporation, Koninklijke Philips N.V., Microsoft Corporation, NVIDIA Corporation, PathAI, Inc., Qiagen N.V., Roche Diagnostics Corporation, Siemens Healthineers, Tempus AI, Inc., and Thermo Fisher Scientific. Actionable Recommendations for Industry Leaders Seeking Competitive Advantage

Leaders looking to leverage digital diagnostics should prioritize strategic investments in research and development to harness new technological advances. Emphasizing collaboration between technology innovators and clinical experts ensures that product development is not only forward-thinking but also closely aligned with patient care needs. It is imperative for organizations to cultivate agile frameworks that enable quick adaptation to technological disruptions and regulatory shifts.

Furthermore, enhancing data integration capabilities across various diagnostic touchpoints will streamline operations and improve the accuracy of clinical decisions. Investing in robust cybersecurity measures is another critical area, as trust becomes an increasingly valued asset in the digital diagnostics arena. Such a focus not only protects sensitive patient data but also enhances overall system reliability and stakeholder confidence.

Developing comprehensive training programs for medical personnel on the new digital tools can smooth the transition to technology-based diagnostics and maximize the return on investment. Additionally, continuous evaluation of market trends and patient needs will empower organizations to align their strategies effectively. By adopting a proactive and forward-looking stance, industry leaders can effectively navigate challenges while capitalizing on emerging market opportunities.

Conclusion: Navigating the Future of Digital Diagnostics with Confidence

The digital diagnostics market stands at the intersection of innovation and clinical excellence. As advanced imaging, real-time monitoring, and digital integration continue to reshape healthcare, it becomes essential for both clinicians and technologists to adopt a unified approach to in-depth diagnostics. The blend of technology and medicine is setting a new benchmark in patient care, offering unprecedented opportunities for early detection, personalized treatments, and finally, improved patient outcomes.

A comprehensive assessment of market segments, regional dynamics, and competitive landscapes reveals a resilient market designed for sustainable growth. Stakeholders who proactively adapt to these shifts are well-positioned to lead this technological revolution and drive the future of healthcare forward. The combined efforts and innovative spirit among industry players herald a promising era where digital solutions empower both clinicians and patients alike, thereby forging a path to a smarter, more efficient healthcare system.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Favorable government policies and regulatory support providing significant impetus to digital diagnostics
      • 5.1.1.2. Increased adoption of telemedicine and remote monitoring solutions fostering digital diagnostics integration
      • 5.1.1.3. Growing prevalence of chronic diseases requiring early detection and precise diagnostic solutions
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with advanced technology implementation and expert workforce training
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of personalized medicine through digital diagnostics by integrating wearable technology
      • 5.1.3.2. Strategic partnerships and collaborations streamlining digital diagnostic workflows with advanced data analytics
    • 5.1.4. Challenges
      • 5.1.4.1. Data privacy concerns and cybersecurity risks undermining consumer trust
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing demand for mobile health (mHealth) diagnostics leveraging smartphone connectivity and portable devices
    • 5.2.2. End-User: Rising application of digital diagnostics in diagnostic laboratories & imaging centers for intelligence-driven analytics to meet these stringent requirements
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Digital Diagnostics Market, by Type

  • 6.1. Introduction
  • 6.2. Digital Dermatology
  • 6.3. Digital Pathology
  • 6.4. Digital Radiology
  • 6.5. Mobile Health (mHealth) Diagnostics
  • 6.6. Molecular & Genetic Diagnostics
  • 6.7. Wearable & Remote Monitoring

7. Digital Diagnostics Market, by Industry Applications

  • 7.1. Introduction
  • 7.2. Cardiology
  • 7.3. Infectious Diseases
  • 7.4. Neurology
  • 7.5. Oncology

8. Digital Diagnostics Market, by End-User

  • 8.1. Introduction
  • 8.2. Diagnostic Laboratories & Imaging Centers
  • 8.3. Hospitals & Clinics
  • 8.4. Research Institutes & Academic Medical Centers

9. Americas Digital Diagnostics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Digital Diagnostics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Digital Diagnostics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2024
  • 12.2. FPNV Positioning Matrix, 2024
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. PocDoc secures GBP 5 million in pre-series A funding to expand its app-based digital diagnostics platform
    • 12.3.2. Digital Diagnostics teams with Google Cloud to accelerate diabetic retinopathy testing in Saudi Arabia
    • 12.3.3. Roche expands digital pathology by integrating over 20 AI algorithms from new collaborators to transform cancer diagnostics
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agilent Technologies
  • 3. Aidoc
  • 4. Becton, Dickinson, and Company
  • 5. Bio-Rad Laboratories
  • 6. Butterfly Network, inc
  • 7. CANON MEDICAL SYSTEMS CORPORATION
  • 8. Carestream Health, Inc.
  • 9. Danaher Corporation
  • 10. FUJIFILM Holdings America Corporation
  • 11. GE Healthcare Technologies, Inc.
  • 12. Google LLC
  • 13. Guardant Health, Inc.
  • 14. Hologic, Inc.
  • 15. International Business Machines Corp.
  • 16. Invitae Corporation
  • 17. Koninklijke Philips N.V.
  • 18. Microsoft Corporation
  • 19. NVIDIA Corporation
  • 20. PathAI, Inc.
  • 21. Qiagen N.V.
  • 22. Roche Diagnostics Corporation
  • 23. Siemens Healthineers
  • 24. Tempus AI, Inc.
  • 25. Thermo Fisher Scientific

LIST OF FIGURES

  • FIGURE 1. DIGITAL DIAGNOSTICS MARKET MULTI-CURRENCY
  • FIGURE 2. DIGITAL DIAGNOSTICS MARKET MULTI-LANGUAGE
  • FIGURE 3. DIGITAL DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 4. DIGITAL DIAGNOSTICS MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 15. AMERICAS DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DIGITAL DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 17. UNITED STATES DIGITAL DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. DIGITAL DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 23. DIGITAL DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. DIGITAL DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIGITAL DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY DIGITAL DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY DIGITAL PATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY DIGITAL RADIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY MOBILE HEALTH (MHEALTH) DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR & GENETIC DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY WEARABLE & REMOTE MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES & IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DIGITAL DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES & ACADEMIC MEDICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES DIGITAL DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA DIGITAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM DIGITAL DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM DIGITAL DIAGNOSTICS MARKET SIZE, BY INDUSTRY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM DIGITAL DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. DIGITAL DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 151. DIGITAL DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024